Ventripoint Diagnostics Ltd. (TSXV:VPT)
Canada · Delayed Price · Currency is CAD 0.0850
-0.0050 (-5.56%)
Sep 22, 2026, 3:55 PM EST
Ventripoint Diagnostics Market Cap
Ventripoint Diagnostics has a market cap or net worth of CAD 17.36 million as of September 22, 2026. Its market cap has decreased by -5.90% in one year.
Market Cap
17.36M
Enterprise Value
19.64M
Revenue
147.77K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.09
ChartMarket Cap Chart
Since September 21, 2007, Ventripoint Diagnostics's market cap has increased from 6.82M to 17.36M, an increase of 154.35%. That is a compound annual growth rate of 5.03%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 21, 2026 | 17.36M | -26.31% |
| Dec 31, 2025 | 23.56M | 45.40% |
| Dec 31, 2024 | 16.20M | -64.98% |
| Dec 29, 2023 | 46.26M | 9.26% |
| Dec 30, 2022 | 42.34M | -21.10% |
| Dec 31, 2021 | 53.67M | 567.95% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Theralase Technologies | 57.44M |
| Cannabix Technologies | 46.68M |
| Perimeter Medical Imaging AI | 43.73M |
| Cheelcare | 34.09M |
| Conavi Medical | 22.08M |
| MedX Health | 16.40M |
| VVT Med | 15.32M |
| Frequency Exchange | 14.44M |